首页 - 股票 - 研报 - 公司研究 - 正文

Dah Sing Financial:The deal is on track

来源:麦格理证券 作者:Elaine Zhou 2016-08-25 00:00:00
关注证券之星官方微博:

The deal is in process: The acquirer, Fujian Thai Hot, is getting regulatoryapprovals in Bermuda, HK and Macau. It might take a couple months as theGroup expected. We expect the deal to be completed in 2016.

There would be special dividends at the Group (440 HK): The Life dealwould bring HK$3.6bn of net proceeds to the Group and HK$2.6bn to theBank (2356 HK, not rated). The Group expects to use the proceeds for specialdividends, working capital and business reinvestment. We are expecting aHK$3.62 of DPS (or a total HK$1.2bn) for each year from FY16-18E. Thisshould bring dividend yield to 7%, and ROE should be sustained at c. 6%.

Operationally, asset quality remains the major concern, althoughmargins improved and loan growth was higher than expected. Keytakeaways include: 1) Reported NIM was enhanced to 1.94% in 1H16 (+4%HoH/+18bp YoY) behind lower funding costs; 2) Loan growth (at 2.1% HoH)was driven by individual loans, and slightly lagged behind the industry pace(at 2.2% HoH); 3) Asset quality deteriorated, as impaired loan ratio rose to1.03% (+28bp HoH). The company explained that it was mainly due to thedeterioration in the HK SME loan book with increased SMEs facingchallenges from their mainland operations. SME accounted for ~30% of totalloan book at the DSB as we calculated; 4) CET 1 was 12.6% in 1H16 (vs12.2% in FY15). But still DPS was cut to 29 cents in 1H16 vs 32 cents in1H15.

We cut net profit by 1% for FY16E (if without divestment gains) and 3% forFY17E. We are forecasting HK$3.6bn of divestment gains for FY16E. We aremore conservative on our dividend forecasts, as we found the Group cut itsinterim DPS despite of the CET 1 enhancement. We are now forecasting aDPS of HK$3.62 for FY16-18E (vs HK$5.82 previously).

The stock is trading at a forward PBV of 0.7x. Our TP of HK$71.16 is basedon a SoTP valuation. This implies a 1.13x of FY16E PBV and ~37% upside tocurrent share price. Although the share price has been driven by the sale ofLife, we believe more upside will be seen given the higher than expected lifepremium and the potential special dividends.





微信
扫描二维码
关注
证券之星微信
APP下载
下载证券之星
郑重声明:以上内容与证券之星立场无关。证券之星发布此内容的目的在于传播更多信息,证券之星对其观点、判断保持中立,不保证该内容(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关内容不对各位读者构成任何投资建议,据此操作,风险自担。股市有风险,投资需谨慎。如对该内容存在异议,或发现违法及不良信息,请发送邮件至jubao@stockstar.com,我们将安排核实处理。如该文标记为算法生成,算法公示请见 网信算备310104345710301240019号。
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-